Search research articles
Contact Us
Filters
Showing results (41-50 of 88) with videos related to
Page
of 9
Sort By:
Journal of Cancer Research and Clinical Oncology
|
October 5, 2019
The effectiveness of Wilms tumor screening in Beckwith-Wiedemann spectrum
Alessandro Mussa, Kelly A Duffy, Diana Carli, et al.
International Journal of Molecular Sciences
|
February 15, 2022
Nanocarrier-Based Delivery of SN22 as a Tocopheryl Oxamate Prodrug Achieves Rapid Tumor Regression and Extends Survival in High-Risk Neuroblastoma Models
Ivan S Alferiev, David T Guerrero, Danielle Soberman, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
February 22, 2022
Poloxamer-linked prodrug of a topoisomerase I inhibitor SN22 shows efficacy in models of high-risk neuroblastoma with primary and acquired chemoresistance
Ivan S Alferiev, David T Guerrero, Peng Guan, et al.
Cancer
|
December 29, 2015
Identification of patient subgroups with markedly disparate rates of MYCN amplification in neuroblastoma: A report from the International Neuroblastoma Risk Group project
Daria Thompson, Kieuhoa T Vo, Wendy B London, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 7, 2009
Trk receptor expression and inhibition in neuroblastomas
Garrett M Brodeur, Jane E Minturn, Ruth Ho, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 17, 2017
Cancer Surveillance in Gorlin Syndrome and Rhabdoid Tumor Predisposition Syndrome
William D Foulkes, Junne Kamihara, D Gareth R Evans, et al.
Pediatric Blood & Cancer
|
May 23, 2019
Comprehensive evaluation of context dependence of the prognostic impact of MYCN amplification in neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project
Kevin Campbell, Derek Shyr, Rochelle Bagatell, et al.
Hormone Research in Paediatrics
|
April 22, 2021
The Clinical Spectrum of PTEN Hamartoma Tumor Syndrome: Exploring the Value of Thyroid Surveillance
Julia A Baran, Steven D Tsai, Amber Isaza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 24, 2005
Hyperdiploidy plus nonamplified MYCN confers a favorable prognosis in children 12 to 18 months old with disseminated neuroblastoma: a Pediatric Oncology Group study
Rani E George, Wendy B London, Susan L Cohn, et al.
JCO Precision Oncology
|
August 13, 2020
Pediatric Somatic Tumor Sequencing Identifies Underlying Cancer Predisposition
Suzanne P MacFarland, Kristin Zelley, Lea F Surrey, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 88) with videos related to
Sort By:
Page
of 9
Journal of Cancer Research and Clinical Oncology
|
October 5, 2019
The effectiveness of Wilms tumor screening in Beckwith-Wiedemann spectrum
Alessandro Mussa, Kelly A Duffy, Diana Carli, et al.
International Journal of Molecular Sciences
|
February 15, 2022
Nanocarrier-Based Delivery of SN22 as a Tocopheryl Oxamate Prodrug Achieves Rapid Tumor Regression and Extends Survival in High-Risk Neuroblastoma Models
Ivan S Alferiev, David T Guerrero, Danielle Soberman, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
February 22, 2022
Poloxamer-linked prodrug of a topoisomerase I inhibitor SN22 shows efficacy in models of high-risk neuroblastoma with primary and acquired chemoresistance
Ivan S Alferiev, David T Guerrero, Peng Guan, et al.
Cancer
|
December 29, 2015
Identification of patient subgroups with markedly disparate rates of MYCN amplification in neuroblastoma: A report from the International Neuroblastoma Risk Group project
Daria Thompson, Kieuhoa T Vo, Wendy B London, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 7, 2009
Trk receptor expression and inhibition in neuroblastomas
Garrett M Brodeur, Jane E Minturn, Ruth Ho, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 17, 2017
Cancer Surveillance in Gorlin Syndrome and Rhabdoid Tumor Predisposition Syndrome
William D Foulkes, Junne Kamihara, D Gareth R Evans, et al.
Pediatric Blood & Cancer
|
May 23, 2019
Comprehensive evaluation of context dependence of the prognostic impact of MYCN amplification in neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project
Kevin Campbell, Derek Shyr, Rochelle Bagatell, et al.
Hormone Research in Paediatrics
|
April 22, 2021
The Clinical Spectrum of PTEN Hamartoma Tumor Syndrome: Exploring the Value of Thyroid Surveillance
Julia A Baran, Steven D Tsai, Amber Isaza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 24, 2005
Hyperdiploidy plus nonamplified MYCN confers a favorable prognosis in children 12 to 18 months old with disseminated neuroblastoma: a Pediatric Oncology Group study
Rani E George, Wendy B London, Susan L Cohn, et al.
JCO Precision Oncology
|
August 13, 2020
Pediatric Somatic Tumor Sequencing Identifies Underlying Cancer Predisposition
Suzanne P MacFarland, Kristin Zelley, Lea F Surrey, et al.
Page
of 9